All Stories

  1. Lues maligna and HIV mimicking aggressive epidermotropic CD8+ cutaneous T-cell lymphoma
  2. COVID ‐19 vaccine‐related eruption of papules and plaques—A case report
  3. Cutaneous manifestations of aortoiliac occlusive disease: two cases and review of the literature
  4. Cutaneous Manifestations and Their Corresponding Dermoscopic Features in Patients with Dermatomyositis
  5. Reticulated atrophic skin lesions in an adult patient with dermatomyositis and antinuclear matrix protein-2 autoantibodies
  6. Histology of Skin Alterations in Lupus Erythematosus
  7. Atopic Dermatitis: From Etiology and History to Treatment
  8. Herpes Simplex Associated Erythema Multiforme: A Case Report and Review of the Literature
  9. The role of IL-17 rs2275913, IL-17RC rs708567 and TGFB1 rs1800469 SNPs and IL-17A serum levels in patients with lupus nephritis
  10. Ultraviolet diagnostic and treatment modalities in the coronavirus disease 2019 pandemic
  11. CD3Z polymorphisms and promoter hypermethylation in dermatomyositis - the role of cytosine-phosphate-guanine-related single nucleotide polymorphisms
  12. Autoimmune connective tissue diseases in the COVID-19 pandemic
  13. Graham-Little-Piccardi-Lassueur Syndrome: Two Case Reports and Review of the Literature
  14. Lupus erythematosus tumidus in an adolescent with beta thalassemia minor successfully controlled with hydroxychloroquine
  15. Recurrent MVD mutation in European patients with disseminated porokeratosis
  16. Klippel-Trenaunay Syndrome Involving Upper Limb and Chest Wall: A Case Report and Review of the Literature
  17. Neurofibromatosis Type I (Von Recklinghausen Disease): A Case Report and Review of the Literature
  18. Correlation of Disease Activity and Quality of Life of Patients with Psoriasis after Narrow-band Ultraviolet B Therapy
  19. XRCC1 variants do not represent a risk for dermatomyositis and systemic lupus erythematosus in Bulgarian patients
  20. Genetically Determined TNF-α Secretion Influences the Development of Dermatomyositis and Systemic Lupus Erythematosus
  21. Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology
  22. Inflammatory Myopathies with Cutaneous Involvement
  23. Association of vitamin D receptor geneBsmI B/b andFokI F/f polymorphisms with adult dermatomyositis and systemic lupus erythematosus
  24. Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses
  25. Monoclonal Antibody treatment for SLE
  26. Association between estrogen receptor-α gene polymorphisms and dermatomyositis in Bulgarian patients
  27. IL-1RN SNP in SLE and DM patients
  28. Nevus Comedonicus: An Updated Review
  29. Role of the Promoter Polymorphism IL-6 −174G/C in Dermatomyositis and Systemic Lupus Erythematosus
  30. Perforating Disseminated Necrobiosis Lipoidica Diabeticorum
  31. TNF-Alpha SNPs in SLE and DM patients
  32. Sarcoidosis and molecular mimicry—important etiopathogenetic aspects: current state and future directions
  33. IL-10 Single Nucleotide Polymorphisms and Lupus-Nephritis
  34. The Coexistence of Systemic Lupus Erythematosus and Thyrotoxicosis: The Diagnostic Value of Antihistone Antibodies
  35. Quantitative Structure-Activity Relationship Modeling of Dermatomyositis Activity of Drug Chemicals
  36. Dermatomyositis
  37. Paraneoplastic dermatological manifestation of gastrointestinal malignancies
  38. Activity of certain drugs in inducing of inflammatory myopathies with cutaneous manifestations
  39. Assen Dourmishev, MD, PhD, DSc, FAAD (1938-2006): Leader of Bulgarian dermatology
  40. Ivermectin: pharmacology and application in dermatology
  41. Segmental ulcerative vasculitis: a cutaneous manifestation of Takayasu's arteritis
  42. Syphilis: Uncommon presentations in adults
  43. Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis
  44. Dermatomyositis: cutaneous manifestations of its variants
  45. D-Penicillamine induced polymyositis and morphea in a woman with Hashimoto thyroiditis
  46. Waardenburg syndrome
  47. Dermatomyositis and Drugs
  48. Dermatomyositis Associated with Malignancy
  49. Efficacy and tolerance of oral ivermectin in scabies
  50. Crusted scabies of the scalp in dermatomyositis patients: three cases treated with oral ivermectin
  51. P169 Oral treatment of scabies
  52. Basal and Squamous Cell Carcinoma: Sex, Age and Location Distribution
  53. Basal and squamous cell carcinoma